Protabit
PrivateLast Round
Grant
Sep 30, 2016
Total Funding Raised
$13.21M
Company Overview
Protabit operates in Healthcare & Life Sciences and is based in Pasadena, California. Its latest recorded funding round was a Grant round in September 2016.
Protabit is a biotechnology company that develops computational protein design software and engineering tools for industrial, agricultural, and healthcare applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Database Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protabit Comparables
Compare Protabit with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyrus Biotechnology | 83% | |
| Biomatter | 80% | |
| Arzeda | 78% |
For institutional investors. Book with your work email.
Protabit Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2016 | ||||
| Grant | Sep 1, 2015 | ||||
| Grant | Sep 1, 2014 | ||||
| Grant | Feb 15, 2014 | ||||
| Grant | Jul 15, 2013 | ||||
Grant | Jul 1, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Protabit Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
| Department of Energy | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 45% MoM, reaching 2.4K.
- Mar 6, 2026
Monthly visitors increased 107% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Protabit Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protabit's valuation, stock price, and market status.
Is Protabit a public or private company?
Protabit is a private company.
What is the current stock price of Protabit?
Protabit is a private company, so its shares have no public market price. Caplight tracks Protabit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protabit worth (valuation)?
Valuation information for Protabit is not publicly available.
Can I buy Protabit stock?
Protabit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protabit's last funding round?
Protabit's most recent funding round was Grant on September 30, 2016.
Who are the main investors in Protabit?
Key investors in Protabit include National Institutes of Health (NIH), Department of Energy, National Science Foundation.
Will Protabit IPO soon?
No public IPO plans have been announced for Protabit.
How can I track Protabit secondary market activity?
Caplight tracks bids, offers, and trades in Protabit's shares on secondary markets.